ALK and anaplastic large cell lymphoma: K-299 and SUDHL, two anaplastic large cell lymphoma (ALCL) cell lines that express NPM-ALK and are dependent on ALK for growth, were used to evaluate the efficacy of GTx-186 and crizotinib.